DUPHAT 2026: Connecting Pakistani Pharmaceutical Businesses with UAE Market Opportunities

DUPHAT 2026, held from 25–27 August 2026 at Dubai World Trade Centre, brought together pharmaceutical and healthcare professionals, global exhibitors, leading brands and industry stakeholders from across the regional and international pharmaceutical community.

Over three days, the exhibition provided a platform for businesses to discover the latest pharmaceutical products and technologies, exchange industry knowledge, build professional connections and explore new commercial opportunities within the region.

For Pakistani pharmaceutical and nutraceutical companies looking to understand and access the UAE market, DUPHAT offered a valuable environment to engage directly with potential business partners and gain first-hand insight into the regional healthcare ecosystem.

Supporting Pakistani Businesses in the UAE Market

Recognising the commercial opportunities presented by the UAE's pharmaceutical and healthcare sector, the International Trade Centre (ITC), in collaboration with Gulf Business Consulting, supported eight leading Pakistani pharmaceutical and nutraceutical companies in exploring the UAE market.

The participating companies were NovaMed Healthcare (Pvt.) Ltd, PharmEvo (Pvt.) Ltd, Blossom Labs (Pvt.) Ltd, CCL Pharma, Atco Labs, Shrooq, Innova, and Tehseen.

The initiative followed a structured two-phase approach. The first phase focused on market prospection and feedback, helping participating businesses assess the UAE's market potential, understand buyer requirements and identify relevant opportunities across the pharmaceutical, nutraceutical, healthcare and related sectors.

Building on this market intelligence, the second phase focused on targeted B2B matchmaking in the UAE, with three leading participating companies engaging directly with potential commercial partners.

Connecting Pakistani Companies with UAE Stakeholders

Through Gulf Business Consulting's support, meetings were facilitated with a range of UAE-based stakeholders, including retailers, distributors, pharmaceutical companies and manufacturers.

Among the organisations engaged during the initiative were Metromed, GAIA Healthcare, AMD Pharmaceuticals, Seha Pharmaceuticals Trading, Kuwait Saudi Pharmaceutical, Al Kenz Pharmaceutical, and Faith Healthcare Group (Azalea Pharma), among others.

These engagements gave Pakistani businesses an opportunity to introduce their products and capabilities, understand the expectations of UAE stakeholders, explore potential areas of collaboration and develop relationships with prospective commercial partners.

From Market Intelligence to Commercial Connections

The initiative went beyond market research by creating opportunities for Pakistani companies to engage directly with the UAE pharmaceutical and healthcare ecosystem.

By combining market intelligence, buyer feedback and targeted B2B matchmaking, Gulf Business Consulting helped participating businesses gain a clearer understanding of the UAE market while establishing connections that can support future market entry and business development.

DUPHAT 2026 therefore served not only as an important industry platform, but also as a valuable setting for Pakistani pharmaceutical businesses to explore the UAE, connect with relevant stakeholders and take practical steps towards developing their presence in the market.